Multinationals have positive views on Korean drug makers
Published: 2008-07-25 07:00:00
Updated: 2008-07-25 07:00:00
Overall, foreign-invested pharmaceutical firms feel that domestic pharmaceutical firms have performed their business operations well in terms of production facilities, licensing procedures and sales activities, according to the Korea Health Industry Development Institute.
A KHIDI report said t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
